Enhanced angiogenic capacity and urokinase-type plasminogen activator expression by endothelial cells isolated from human endometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3359-3367

  Koolwijk, Pieter ^a   Kapiteijn, Kitty ^a,b   Molenaar, Bibi ^a,b   Van Spronsen, Erik ^a   Van Der Vecht, Bea ^a   Helmerhorst, Frans M ^b   Van Hinsbergh, Victor W M ^c  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOMETRIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; NIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REPRODUCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION;

EID: 0034924665     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.7.7651     Document Type: Article

References (44)

1. Angiogenesis in the endometrium
2. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle
3. Paracrine action of vascular endothelial growth factor in the human endometrium: Production and target sites, and hormonal regulation
4. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells
5. Angiogenesis
6. Manipulating angiogenesis: From basic science to the bedside
7. Endometrial angiogenesis
8. Impact of endothelial activation on fibrinolysis and local proteolysis in tissue repair
9. Membrane proteases in focus
10. Proteolytic activation of fine precursor of membrane type 1 matrix metalloproteinase by human plasmin: A possible cell surface activator
11. Membrane-associated procollagenase of leukemic cells Is activated by urokinase-type plasminogen activator
12. Mechanisms for pro matrix metalloproteinase activation
13. Functional heterogeneity of vascular endothelial cells
14. Endometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue response to angiogenic growth factors
15. Human endometrial endothelial cells: Isolation, characterization, and inflammatory-mediated expression of tissue factor and type 1 plasminogen activator inhibitor
16. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
17. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization
18. 2-integrins, and Src-kinases within a single receptor complex of human monocytes
19. Demonstration of urokinase-related fibrinolytic activity in human plasma
20. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors
21. Differential expression of the two VEGF receptors Flt and Kdr in placenta and vascular endothelial cells
22. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
23. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells
24. 1 integrin on human endothelial cells
25. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
26. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
27. Collagen as a substrate for cell growth and differentiation
28. Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity
29. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells
30. Apoptosis of human ovary and uterine endometrium during the menstrual cycle
31. Tumor angiogenesis
32. Molecular and biological properties of vascular endothelial growth factor
33. Immunolocalisation of vascular endothelial growth factor in human endometrium
34. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium
35. Expression of vascular endothelial growth factor receptors in the human endometrium: Modulation during the menstrual cycle
36. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor sflt in cycling human endometrium
37. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
38. Systemic activation of the vascular endothelial growth factor receptor KDR/flk-1 selectively triggers endothelial cells with an angiogenic phenotype
39. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells
40. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: Implications for capillary-like tube formation in a fibrin matrix
41. Tumor necrosis factor induction of endothelial cell urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by γ-interferon
42. Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix
43. Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma
44. Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels